fda compounded semaglutide news 🚨 Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA Ban on Compounded GLP-1

Appetite drops on Ozempic, Wegovy, and Zepbound, but nutrition needs remain

Policy and Global Health Policy advances in 2025 laid critical groundwork for the next phase of obesity care

Nausea is one of the most common side effects when starting semaglutide therapy, but it's usually temporary

Bay State Milling executive sees key opportunity for baking industry.

This program will help you educate your patients on how to use the medication and how they can keep the weight off for good with lifestyle change.

Where to inject retatrutide: learn the recommended subcutaneous injection sites, step-by-step technique, site rotation guidance, and common mistakes to avoid all aligned with UK clinical best practice.